The gene methylation panel based on ZNF582 and PAX1 yielded a sensitivity ranging from 31% for hyperplasia/hyperkeratosis to 90% for moderate dysplasia oral lesions [15]. The gene discussed is ZNF582; the disease is Hyperkeratosis.